glp-1 receptor agonist drugs list Mapping the effectiveness and risks of agonists While GLP-1 receptor agonists are

This led to the US FDA approval of Ozempic to reduce cardiovascular risk in this specific patient population in 2020 In the HARMONY Outcomes trial, patients with type 2 diabetes and cardiovascular disease who took the GLP-1 medication saw a 22% reduction in major adverse cardiovascular events compared to placebo

doi: 10.1056/NEJMoa2032183 [DOI] [PubMed] [Google Scholar] 77.Jastreboff AM, Aronne LJ, Ahmad NN, et al

The glucagon pathway in particular produces effects, including thermogenesis and hepatic lipid mobilization, that no prior GLP-1 or GLP-1/GIP compound prepared the body for

Glucose Regulation: They tell your liver to stop producing unnecessary extra sugar